VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
BRENNER, MALCOLM
One or more keywords matched the following items that are connected to
BRENNER, MALCOLM
Item Type
Name
Academic Article
Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment.
Academic Article
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
Academic Article
The eyes have it.
Academic Article
T cell receptors and cancer: gain gives pain.
Academic Article
Genetic modification of T lymphocytes for adoptive immunotherapy.
Academic Article
Adoptive T cell therapy of cancer.
Academic Article
Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b.
Concept
Transgenes
Academic Article
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.
Academic Article
Reversal of tumor immune inhibition using a chimeric cytokine receptor.
Academic Article
Clonal Dynamics In Vivo of Virus Integration Sites of T Cells Expressing a Safety Switch.
Academic Article
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells.
Academic Article
iCaspase 9 Suicide Gene System.
Academic Article
Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.
Academic Article
Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.
Academic Article
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.
Academic Article
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia.
Search Criteria
Transgenes